Avid Bioservices Inc (CDMO)
11.34
+0.17
(+1.52%)
USD |
NASDAQ |
Sep 27, 16:00
11.34
0.00 (0.00%)
After-Hours: 20:00
Avid Bioservices SG&A Expense (TTM): 27.90M for July 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
July 31, 2024 | 27.90M |
April 30, 2024 | 26.00M |
January 31, 2024 | 26.76M |
October 31, 2023 | 27.49M |
July 31, 2023 | 27.76M |
April 30, 2023 | 27.88M |
January 31, 2023 | 26.24M |
October 31, 2022 | 24.95M |
July 31, 2022 | 23.15M |
April 30, 2022 | 21.23M |
January 31, 2022 | 20.37M |
October 31, 2021 | 18.57M |
July 31, 2021 | 17.70M |
April 30, 2021 | 17.06M |
January 31, 2021 | 15.54M |
October 31, 2020 | 14.52M |
July 31, 2020 | 13.88M |
April 30, 2020 | 14.52M |
January 31, 2020 | 14.56M |
October 31, 2019 | 14.81M |
July 31, 2019 | 14.09M |
April 30, 2019 | 12.85M |
January 31, 2019 | 13.46M |
October 31, 2018 | 15.04M |
July 31, 2018 | 15.82M |
Date | Value |
---|---|
April 30, 2018 | 16.46M |
January 31, 2018 | 16.75M |
October 31, 2017 | 16.29M |
July 31, 2017 | 17.68M |
April 30, 2017 | 18.89M |
January 31, 2017 | 18.47M |
October 31, 2016 | 18.63M |
July 31, 2016 | 18.06M |
April 30, 2016 | 17.90M |
January 31, 2016 | 19.03M |
October 31, 2015 | 18.83M |
July 31, 2015 | 18.71M |
April 30, 2015 | 18.69M |
January 31, 2015 | 17.86M |
October 31, 2014 | 18.10M |
July 31, 2014 | 17.82M |
April 30, 2014 | 17.27M |
January 31, 2014 | 16.58M |
October 31, 2013 | 15.13M |
July 31, 2013 | 14.55M |
April 30, 2013 | 13.13M |
January 31, 2013 | 12.56M |
October 31, 2012 | 12.16M |
July 31, 2012 | 11.45M |
April 30, 2012 | 11.46M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
13.88M
Minimum
Jul 2020
27.90M
Maximum
Jul 2024
21.04M
Average
20.80M
Median
SG&A Expense (TTM) Benchmarks
MEI Pharma Inc | 23.30M |
Altimmune Inc | 19.75M |
NovaBay Pharmaceuticals Inc | 11.53M |
Palatin Technologies Inc | 13.34M |
iBio Inc | 11.67M |